Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vamousse Spray 'n' Go vs Permethrin for Head Lice
NCT05565820Phase 4Completed
- Sponsor
- Alliance Pharma
- Start
- Dec 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Vamousse Spray 'n' Go in pediculosis capitis, sponsored by Alliance Pharma. Primary endpoint: Proportion of Participants Who Are Completely Free of Live Lice at Day 14. Started Dec 2022; status: completed.
02
Drugs
Vamousse Spray 'n' Go
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on NCT05565820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05565820.